Paper · 42730833
Overcoming cancer resistance in pancreatic cancer: toward dynamic precision oncology.
Okabayashi T and 4 others. Mol Biol Rep, 2026. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Overcoming cancer resistance in pancreatic cancer: toward dynamic precision oncology. Papers, record 42730833. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42730833
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Precision Medicine | Major topic |
| Drug Resistance, Neoplasm | Major topic |
| Pancreatic Neoplasms | Major topic |
| Carcinoma, Pancreatic Ductal | Major topic |
| Humans | |
| Tumor Microenvironment | |
| Biomarkers, Tumor |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38,194,153 | Deciphering cellular plasticity in pancreatic cancer for effective treatments. | Cancer Metastasis Rev | 2024 | https://conductscience.org/library/papers/38194153 | PubMed |
| 2 | 39,808,248 | The Current Role of Circulating Tumor DNA in the Management of Pancreatic Cancer. | J Gastrointest Cancer | 2025 | https://conductscience.org/library/papers/39808248 | PubMed |
| 3 | 40,494,489 | Structure-activity relationships of KRAS-G12D inhibitors for pancreatic cancer. | Drug Discov Today | 2025 | https://conductscience.org/library/papers/40494489 | PubMed |
| 4 | 39,243,602 | Unveiling the resistance to therapies in pancreatic ductal adenocarcinoma. | Drug Resist Updat | 2024 | https://conductscience.org/library/papers/39243602 | PubMed |
| 5 | 35,809,752 | ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group. | Ann Oncol | 2022 | https://conductscience.org/library/papers/35809752 | PubMed |
| 6 | 38,229,153 | Pancreatic cancer acquires resistance to MAPK pathway inhibition by clonal expansion and adaptive DNA hypermethylation. | Clin Epigenetics | 2024 | https://conductscience.org/library/papers/38229153 | PubMed |
| 7 | 39,658,630 | Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal adenocarcinoma. | Nat Biomed Eng | 2025 | https://conductscience.org/library/papers/39658630 | PubMed |
| 8 | 39,571,764 | New insight into the role of SMAD4 mutation/deficiency in the prognosis and therapeutic resistance of pancreatic ductal adenocarcinomas. | Biochim Biophys Acta Rev Cancer | 2024 | https://conductscience.org/library/papers/39571764 | PubMed |
| 9 | 37,537,300 | Cancer cell plasticity during tumor progression, metastasis and response to therapy. | Nat Cancer | 2023 | https://conductscience.org/library/papers/37537300 | PubMed |
| 10 | 41,044,427 | The tumour microenvironment in pancreatic cancer - new clinical challenges, but more opportunities. | Nat Rev Clin Oncol | 2025 | https://conductscience.org/library/papers/41044427 | PubMed |
1 to 10 of 41
See all 41 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
None in this release.
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| KRAS | 3,845 | PubTator's text mining | https://conductscience.org/library/genes/3845 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42730833
GET https://conductscience.org/api/papers/v1/42730833/references?page=2